Apply to trial NCT07213154

A few quick questions so the study team can decide if you might be a fit.

RecruitingProcedure

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening